| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment.
|
J Hepatol
|
2002
|
1.96
|
|
2
|
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.
|
Nat Genet
|
2010
|
1.43
|
|
3
|
Occult cytomegalovirus cholangitis as a potential cause of cholestatic complications after orthotopic liver transplantation? A study of cytomegalovirus DNA in bile.
|
Liver Transpl
|
2013
|
1.42
|
|
4
|
Fulminant hepatic failure: etiology and indications for liver transplantation.
|
Nephrol Dial Transplant
|
2007
|
1.39
|
|
5
|
Immunosuppression and modulation in liver transplantation.
|
Nephrol Dial Transplant
|
2004
|
1.03
|
|
6
|
Radiologic versus endoscopic evaluation of the conduit after esophageal resection: a prospective, blinded, intraindividually controlled diagnostic study.
|
Surg Endosc
|
2014
|
0.99
|
|
7
|
Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation.
|
BMC Gastroenterol
|
2009
|
0.97
|
|
8
|
Bacteriobilia and fungibilia are associated with outcome in patients with endoscopic treatment of biliary complications after liver transplantation.
|
Endoscopy
|
2013
|
0.96
|
|
9
|
A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
|
Hepatology
|
2008
|
0.96
|
|
10
|
Surgical treatment of primary hepatic epithelioid hemangioendothelioma.
|
Transplantation
|
2005
|
0.96
|
|
11
|
Review of the clinical experience with a modified release form of tacrolimus [FK506E (MR4)] in transplantation.
|
Clin Transplant
|
2006
|
0.91
|
|
12
|
Outcome and development of symptoms after orthotopic liver transplantation for Wilson disease.
|
Clin Transplant
|
2013
|
0.90
|
|
13
|
FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis.
|
J Hepatol
|
2013
|
0.88
|
|
14
|
The inhibitors of nucleotide biosynthesis leflunomide, FK778, and mycophenolic acid activate hepatitis B virus replication in vitro.
|
Hepatology
|
2012
|
0.88
|
|
15
|
Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate.
|
Hepatology
|
2003
|
0.87
|
|
16
|
Living related liver transplantation: the ultimate technique to expand the donor pool?
|
Transplantation
|
2005
|
0.86
|
|
17
|
Non-IBD immunological diseases are a risk factor for reduced survival in PSC.
|
Liver Int
|
2012
|
0.86
|
|
18
|
Risk factors and outcome in patients with primary sclerosing cholangitis with persistent biliary candidiasis.
|
BMC Infect Dis
|
2014
|
0.85
|
|
19
|
Primary sclerosing cholangitis: diagnostic and therapeutic problems.
|
Dig Dis
|
2011
|
0.85
|
|
20
|
Indications for intestinal transplantation: recognizing the scope and limits of total parenteral nutrition.
|
Clin Transplant
|
2013
|
0.84
|
|
21
|
Persistent ascites after liver transplantation: etiology, treatment and impact on survival.
|
Ann Transplant
|
2013
|
0.84
|
|
22
|
Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG).
|
Eur J Radiol
|
2011
|
0.84
|
|
23
|
Biliary candida infections in primary sclerosing cholangitis.
|
J Hepatol
|
2006
|
0.83
|
|
24
|
Prophylaxis and treatment of recurrent viral hepatitis after liver transplantation.
|
Nephrol Dial Transplant
|
2007
|
0.82
|
|
25
|
A routine liver transplantation in a patient with situs inversus: a case report and an overview of the literature.
|
Clin Transplant
|
2006
|
0.82
|
|
26
|
Pruritus is associated with severely impaired quality of life in patients with primary sclerosing cholangitis.
|
Eur J Gastroenterol Hepatol
|
2014
|
0.82
|
|
27
|
Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature.
|
Nephrol Dial Transplant
|
2007
|
0.82
|
|
28
|
New aspects on reperfusion injury to liver--impact of organ harvest.
|
Nephrol Dial Transplant
|
2004
|
0.82
|
|
29
|
Antibiotic prophylaxis after variceal hemorrhage reduces incidence of early rebleeding.
|
Hepatogastroenterology
|
2004
|
0.82
|
|
30
|
S100A9 is a biliary protein marker of disease activity in primary sclerosing cholangitis.
|
PLoS One
|
2012
|
0.81
|
|
31
|
CYP3A activity in severe liver cirrhosis correlates with Child-Pugh and model for end-stage liver disease (MELD) scores.
|
Br J Clin Pharmacol
|
2014
|
0.81
|
|
32
|
Acute increase in hepatic arterial flow during TIPS identified by intravascular flow measurements.
|
Cardiovasc Intervent Radiol
|
2008
|
0.80
|
|
33
|
Prevention of hepatitis B virus recurrence after liver transplantation.
|
Clin Transplant
|
2006
|
0.80
|
|
34
|
Factors influencing long-term quality of life and depression in German liver transplant recipients: a single-centre cross-sectional study.
|
Ann Transplant
|
2013
|
0.80
|
|
35
|
Liver transplantation for metabolic liver diseases in adults: indications and outcome.
|
Nephrol Dial Transplant
|
2007
|
0.79
|
|
36
|
A frequent PNPLA3 variant is a sex specific disease modifier in PSC patients with bile duct stenosis.
|
PLoS One
|
2013
|
0.79
|
|
37
|
Myocardial late gadolinium enhancement cardiovascular magnetic resonance in patients with cirrhosis.
|
J Cardiovasc Magn Reson
|
2010
|
0.79
|
|
38
|
Budd-Chiari syndrome: long term success via hepatic decompression using transjugular intrahepatic porto-systemic shunt.
|
BMC Gastroenterol
|
2010
|
0.78
|
|
39
|
Evolution of liver transplantation at the University of Heidelberg: interventions influencing patient referral.
|
Transplantation
|
2005
|
0.77
|
|
40
|
Gastrointestinal complaints in runners are not due to small intestinal bacterial overgrowth.
|
J Negat Results Biomed
|
2011
|
0.77
|
|
41
|
Kinetics of primary bile acids in patients after proctocolectomy and ileal pouch-anal anastomosis.
|
Digestion
|
2014
|
0.76
|
|
42
|
Heidelberg's first experiences in establishing a living-donation liver transplantation programme.
|
Nephrol Dial Transplant
|
2004
|
0.76
|
|
43
|
Right porto-ovarian H-shunt for the surgical treatment of symptomatic portal biliopathy: a case report and literature review.
|
HPB Surg
|
2009
|
0.76
|
|
44
|
Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
45
|
Microbiological Assessment of Bile and Corresponding Antibiotic Treatment: A Strobe-Compliant Observational Study of 1401 Endoscopic Retrograde Cholangiographies.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
46
|
Biliary phosphatidylcholine and lysophosphatidylcholine profiles in sclerosing cholangitis.
|
World J Gastroenterol
|
2013
|
0.75
|
|
47
|
Versatile inlet system for on-line compound-specific deltaD and delta13C gas chromatography-oxidation/reduction-isotope ratio mass spectrometry analysis of gaseous mixtures.
|
Rapid Commun Mass Spectrom
|
2007
|
0.75
|
|
48
|
Cost distribution of orthotopic liver transplantation: single-center analysis under DRG-based reimbursement.
|
Transplantation
|
2005
|
0.75
|
|
49
|
[Off-label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
|
Med Klin (Munich)
|
2005
|
0.75
|
|
50
|
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
|
Transplantation
|
2005
|
0.75
|
|
51
|
Acute liver failure after a late TIPSS revision.
|
Cardiovasc Intervent Radiol
|
2007
|
0.75
|
|
52
|
The ongoing need for innovation in transplant medicine and surgery.
|
Transplantation
|
2005
|
0.75
|
|
53
|
Treatment of hepatitis C virus reinfection after liver transplantation.
|
Transplantation
|
2005
|
0.75
|
|
54
|
Cellular growth inhibition by FK778 is linked to G1 arrest or S phase accumulation, dependent on the functional status of the retinoblastoma protein.
|
Int J Mol Med
|
2009
|
0.75
|
|
55
|
Balloon Dilatation of the Minor Duodenal Papilla Up to 4 mm is Safe in a Porcine Model.
|
Surg Laparosc Endosc Percutan Tech
|
2017
|
0.75
|
|
56
|
[Off label use in long-term anticoagulation after liver transplantation due to phenprocoumon-induced hepatic failure].
|
Med Monatsschr Pharm
|
2006
|
0.75
|